Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Total Liabilities (2022 - 2023)

Historic Total Liabilities for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $32.5 million.

  • Lexeo Therapeutics' Total Liabilities fell 6716.54% to $32.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $32.5 million, marking a year-over-year decrease of 6716.54%. This contributed to the annual value of $25.0 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Lexeo Therapeutics reported Total Liabilities of $32.5 million as of Q3 2023, which was down 6716.54% from $25.0 million recorded in Q4 2022.
  • In the past 5 years, Lexeo Therapeutics' Total Liabilities ranged from a high of $99.0 million in Q3 2022 and a low of $25.0 million during Q4 2022